Pro Share Advisors LLC Kura Oncology, Inc. Transaction History
Pro Share Advisors LLC
- $48.7 Billion
- Q2 2025
A detailed history of Pro Share Advisors LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 19,449 shares of KURA stock, worth $187,099. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,449
Previous 19,665
1.1%
Holding current value
$187,099
Previous $129,000
13.18%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding KURA
# of Institutions
191Shares Held
79.8MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$78.1 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$74.6 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$67 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$59.6 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$51.5 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $644M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...